FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976484734> ?p ?o ?g. }

• W1976484734 endingPage "431" @default.
• W1976484734 startingPage "427" @default.
• W1976484734 abstract "Purpose Many cooperative groups have reported on the chemo-sensitivity of rhabdomyosarcoma (RMS). Doxorubicin has been tested but remains a controversial treatment option. We report here the results of the up-front evaluation of the efficacy of doxorubicin in children and adolescents with high-risk metastatic RMS. Patients and methods Patients younger than 18 years of age (>6 months) with newly diagnosed, histologically confirmed high-risk metastatic RMS were required to have measurable disease, to have undergone no prior chemotherapy or radiation therapy and to have normal liver, renal and cardiac function before treatment. Doxorubicin was administered intravenously over 48 h to a total dose of 60 mg/m2. Two courses were given separated by a 21 day interval. Response to therapy was assessed by diagnostic imaging after the second course. The study was designed as a two-stage procedure according to the multistep plan described by Fleming. Results Twenty patients were eligible for analysis. Median age at diagnosis was 9.8 years (range from 2 to 16). Thirteen of the 20 patients treated in the first step responded to treatment, corresponding to an overall response to doxorubicin of 65% [95% confidence interval (CI), 44–85%]. The rates of CR and PR were 5% [95% CI, 0–14%] and 60% [95% CI, 39–81%], respectively. Four (20%) patients had progressive disease, corresponding to a progression rate of 20% [95% CI, 2–38%]. Conclusion This window study provides the definitive demonstration of the efficacy of doxorubicin in untreated RMS. Given the inconclusive results obtained from previous studies using differing schedules chemotherapy incorporating doxorubicin, the next step should be a randomised study testing dose intensity in high-risk localised RMS. This issue is being addressed in a current European study (EpSSG RMS 2005)." @default.
• W1976484734 created "2016-06-24" @default.
• W1976484734 creator A5007907029 @default.
• W1976484734 creator A5022487325 @default.
• W1976484734 creator A5037694078 @default.
• W1976484734 creator A5042558055 @default.
• W1976484734 creator A5049976740 @default.
• W1976484734 creator A5056522286 @default.
• W1976484734 creator A5061565715 @default.
• W1976484734 creator A5064732106 @default.
• W1976484734 creator A5067218613 @default.
• W1976484734 creator A5076633760 @default.
• W1976484734 creator A5081476373 @default.
• W1976484734 date "2008-02-01" @default.
• W1976484734 modified "2023-09-23" @default.
• W1976484734 title "Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease" @default.
• W1976484734 cites W1494946180 @default.
• W1976484734 cites W1693048258 @default.
• W1976484734 cites W1888038496 @default.
• W1976484734 cites W1892579032 @default.
• W1976484734 cites W1984254136 @default.
• W1976484734 cites W1985006583 @default.
• W1976484734 cites W2024841231 @default.
• W1976484734 cites W2026516892 @default.
• W1976484734 cites W2082065626 @default.
• W1976484734 cites W2083765984 @default.
• W1976484734 cites W2092722132 @default.
• W1976484734 cites W2107307464 @default.
• W1976484734 cites W2113863686 @default.
• W1976484734 cites W2156822604 @default.
• W1976484734 cites W2161378536 @default.
• W1976484734 doi "https://doi.org/10.1016/j.ejca.2007.12.007" @default.
• W1976484734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18215514" @default.
• W1976484734 hasPublicationYear "2008" @default.
• W1976484734 type Work @default.
• W1976484734 sameAs 1976484734 @default.
• W1976484734 citedByCount "32" @default.
• W1976484734 countsByYear W19764847342012 @default.
• W1976484734 countsByYear W19764847342013 @default.
• W1976484734 countsByYear W19764847342014 @default.
• W1976484734 countsByYear W19764847342015 @default.
• W1976484734 countsByYear W19764847342016 @default.
• W1976484734 countsByYear W19764847342017 @default.
• W1976484734 countsByYear W19764847342018 @default.
• W1976484734 countsByYear W19764847342020 @default.
• W1976484734 countsByYear W19764847342021 @default.
• W1976484734 countsByYear W19764847342022 @default.
• W1976484734 countsByYear W19764847342023 @default.
• W1976484734 crossrefType "journal-article" @default.
• W1976484734 hasAuthorship W1976484734A5007907029 @default.
• W1976484734 hasAuthorship W1976484734A5022487325 @default.
• W1976484734 hasAuthorship W1976484734A5037694078 @default.
• W1976484734 hasAuthorship W1976484734A5042558055 @default.
• W1976484734 hasAuthorship W1976484734A5049976740 @default.
• W1976484734 hasAuthorship W1976484734A5056522286 @default.
• W1976484734 hasAuthorship W1976484734A5061565715 @default.
• W1976484734 hasAuthorship W1976484734A5064732106 @default.
• W1976484734 hasAuthorship W1976484734A5067218613 @default.
• W1976484734 hasAuthorship W1976484734A5076633760 @default.
• W1976484734 hasAuthorship W1976484734A5081476373 @default.
• W1976484734 hasConcept C126322002 @default.
• W1976484734 hasConcept C141071460 @default.
• W1976484734 hasConcept C142724271 @default.
• W1976484734 hasConcept C146357865 @default.
• W1976484734 hasConcept C151730666 @default.
• W1976484734 hasConcept C2776694085 @default.
• W1976484734 hasConcept C2778256501 @default.
• W1976484734 hasConcept C2780844630 @default.
• W1976484734 hasConcept C2781303535 @default.
• W1976484734 hasConcept C44249647 @default.
• W1976484734 hasConcept C71924100 @default.
• W1976484734 hasConcept C86803240 @default.
• W1976484734 hasConcept C90924648 @default.
• W1976484734 hasConceptScore W1976484734C126322002 @default.
• W1976484734 hasConceptScore W1976484734C141071460 @default.
• W1976484734 hasConceptScore W1976484734C142724271 @default.
• W1976484734 hasConceptScore W1976484734C146357865 @default.
• W1976484734 hasConceptScore W1976484734C151730666 @default.
• W1976484734 hasConceptScore W1976484734C2776694085 @default.
• W1976484734 hasConceptScore W1976484734C2778256501 @default.
• W1976484734 hasConceptScore W1976484734C2780844630 @default.
• W1976484734 hasConceptScore W1976484734C2781303535 @default.
• W1976484734 hasConceptScore W1976484734C44249647 @default.
• W1976484734 hasConceptScore W1976484734C71924100 @default.
• W1976484734 hasConceptScore W1976484734C86803240 @default.
• W1976484734 hasConceptScore W1976484734C90924648 @default.
• W1976484734 hasIssue "3" @default.
• W1976484734 hasLocation W19764847341 @default.
• W1976484734 hasLocation W19764847342 @default.
• W1976484734 hasOpenAccess W1976484734 @default.
• W1976484734 hasPrimaryLocation W19764847341 @default.
• W1976484734 hasRelatedWork W1986439267 @default.
• W1976484734 hasRelatedWork W2003938723 @default.
• W1976484734 hasRelatedWork W2047967234 @default.
• W1976484734 hasRelatedWork W2118496982 @default.
• W1976484734 hasRelatedWork W2155391523 @default.
• W1976484734 hasRelatedWork W2364998975 @default.
• W1976484734 hasRelatedWork W2439875401 @default.

• next